CD79A and CD79B were previously reported as significantly down-regulated by EBNA2 in the B cell lymphoma cell line BJAB [17], but in our Taqman analysis using duplicate ER-EB 2.5 RNA samples, repression of these genes did not reach statistical significance. This evidence concerns the gene CD79A and B-cell non-Hodgkin lymphoma.